Table S1. Characteristics associated with frequency of nut consumption (full entire sample; Nn=4,416).
|
|
- Mervyn Webster
- 5 years ago
- Views:
Transcription
1 Table S1. Characteristics associated with frequency of nut (full entire sample; Nn=4,416). Daily nut Nn= 212 Weekly nut Nn= 487 Monthly nut Nn= 1,276 Infrequent or never nut Nn= 2,441 Sex; n (%) men 52 (24.5) 144 (29.6) 490 (38.6) 1017 (41.7) women 160 (75.5) 343 (70.4) 786 (61.6) 1424 (58.3) Age (years); median (interquartile range (, 58.0 (19.75) 53.0 (21.0) 51.0 (22.0) 56.0 (23.0) IQR)) Education (years of schooling); 12.0 (4.0) 12.0 (3.0) 12.0 (3.0) 12.0 (4.0) median (IQR) Material status; median (IQR) 11.0 (4.0) 11.0 (4.0) 11.0 (4.0) 10.0 (4.0) Smoking; n (%) current smokers 41 (19.3) 115 (23.6) 361 (28.3) 690 (28.3) ex-smokers 55 (25.9) 114 (23.4) 315 (24.7) 636 (26.1) never-smokers 116 (54.7) 258 (53.0) 600 (47.0) 1115 (45.7) Alcohol intake; n (%) excessive 32 (15.1) 70 (14.4) 225 (17.6) 437 (17.9) moderate 90 (42.5) 248 (50.9) 631 (49.5) 1069 (43.8) none 90 (42.5) 169 (34.7) 420 (32.9) 935 (38.3) MDSS 14 points; n (%) 147 (69.3) 189 (38.8) 301 (23.6) 637 (26.1) Physical activity; n (%) light 51 (24.1) 122 (25.1) 304 (23.8) 612 (25.1) moderate 147 (69.3) 342 (70.2) 852 (66.8) 1532 (62.8) intensive 14 (6.6) 23 (4.7) 120 (9.4) 295 (12.1) BMI (kg/m 2 ); n (%) 25.0 (normal) 102 (48.1) 242 (49.7) 605 (47.4) 984 (40.3) (overweight) 83 (39.2) 172 (35.3) 464 (36.4) 971 (39.8) 30.0 (obese) 27 (12.7) 73 (15.0) 207 (16.2) 486 (19.9) Waist circumference ( 94 cm, 80cm ); n (%) 169 (80.1) 360 (74.2) 919 (72.5) 1909 (78.9) WHR ( 0.90, 0.85 ); n (%) 137 (64.9) 296 (61.0) 805 (63.6) 1800 (74.6) Overall pp (post-hoc test p-vp values) <0.001 (0.173 DW, <0.001 DM, <0.001 DN WM, <0.001 WN, MN ) <0.001 (<0.001 DW, <0.001 DM, DN WM, <0.001 WN, <0.001 (0.438 DW, DM, <0.001 DN WM, <0.001 WN, <0.001 (0.073 DW, DM, <0.001 DN, WM, <0.001 WN, (0.431 DW, DM, DN, WM, WN, MN ) (0.098 DW, DM, DN, WM, WN, MN ) <0.001 (<0.001 DW, <0.001 DM, <0.001 DN, <0.001 WM, <0.001 WN, MN ) <0.001 (0.588 DW, DM, DN, WM, <0.001 WN, MN ) <0.001 (0.550 DW, DM, DN, WM, <0.001 WN, <0.001 (0.096 DW, DM, DN, WM, WN, <0.001 (0.330 DW, DM, DN, WM, <0.001 WN,
2 WHtR ( 0.5); n % 159 (75.4) 348 (71.8) 932 (73.6) 1975 (81.7) Cholesterol ( 5 mmol/l); n (%) HDL ( 1.03 mmol/l, 1.29 mmol/l ); n (%) 164 (77.4) 378 (77.6) 892 (69.9) 1841 (75.4) 35 (16.5) 95 (19.5) 231 (18.1) 493 (20.2) LDL ( 3 mmol/l); n (%) 158 (74.5) 377 (77.4) 884 (69.3) 1795 (73.5) Triglycerides ( 1.7 mmol/l); n (%) 41 (19.3) 106 (21.8) 302 (23.7) 714 (29.3) CHD; n (%) 13 (6.1) 25 (5.1) 59 (4.6) 244 (10.0) CVI; n (%) 4 (1.9) 8 (1.6) 17 (1.3) 66 (2.7) Hypertension (Systolic 140 mmhg or Diastolic 90 mmhg or treated for hypertension); n (%) Diabetes ( 7 mmol/l or treated for diabetes type 2); n (%) HbA1c ( 6.5 mmol/l or treated for diabetes); n (%) 73 (34.4) 141 (29.0) 391 (30.7) 896 (36.8) 20 (9.4) 39 (8.0) 105 (8.2) 318 (13.0) 19 (9.0) 35 (7.2) 85 (6.7) 255 (10.4) Metabolic syndrome; n (%) 87 (42.6) 189 (39.5) 471 (39.0) 1258 (52.3) Gout (Uric acid 404 μmol/l, 338 μmol/l or gout); n (%) 34 (16.9) 71 (15.0) 191 (16.0) 513 (21.6) <0.001 (0.326 DW, DM, DN, WM, <0.001 WN, <0.001 (0.940 DW, DM, DN, WM, WN, (0.349 DW, DM, DN, WM, WN, MN ) (0.408 DW, DM, DN, WM, WN, MN ) <0.001 (0.469 DW, DM, DN, WM, WN, <0.001 (0.592 DW, DM, DN, WM, WN, (0.819 DW, DM, DN, WM, WN, MN ) <0.001 (0.148 DW, DM, DN, WM, WN, <0.001 (0.533 DW, DM, DN, WM, WN, (0.419 DW, DM, DN, WM, WN, <0.001 (0.449 DW, DM, DN, WM, <0.001 WN, <0.001 (0.526 DW, DM, DN, WM, WN, MDSS - Mediterranean Diet Serving Score. BMI - body mass index. WHR waist-to-hip ratio. WHtR waist-to-height ratio. CHD - coronary heart disease. CVI - cerebrovascular insult. : males. : woman. p-values for categorical variables were obtained with chi-squared test, and for numerical with Kruskal-Wallis test. Post-hoc test P p-values values for categorical variables were obtained with chi-squared test, and for numerical with Mann-Whitney U test. DW Post-hoc test Pp-V value: Daily daily vs. Weeklyweekly. DM Post-hoc test p- value: Daily daily vs. Monthlymonthly. DN Post-hoc test p- value: Daily daily vs. Nevernever. WM Post-hoc test p- value: Weekly weekly vs. Monthlymonthly. WN Post-hoc test p- value: Weekly weekly vs. Infrequentlyinfrequently or never. MN Post-hoc test p- value: Monthly monthly vs. Infrequentlyinfrequently or never.
3 Formatted: MDPI_3.1_text Table S2. Characteristics associated with unfavorable biochemical parameters; lipid levels as determined by the multivariate logistic regression models and elevated fibrinogen as determined by ordinal regression model (sample size is 897 participants subjects without previous cardiovascular diseasecvd diagnosis and older than 65 years of age; all independent variables included in the model are listed in the table). Sex (referent ([ref)]: female) Cholesterol ( 5 mmol/l) confidence interval); Pp-Value LDL ( 3 mmol/l) HDL ( 1.03 mmol/l, 1.29 mmol/l ) Triglycerides ( 1.7 mmol/l) Fibrinogen ( 4.0 g/l is referent) male 0.67 ( ); ( ); ( ); < ( ); ( ); Age (years) median (interquartile range (IQR)) Place of residence (ref: Split) 0.96 ( ); ( ); ( ); ( ); ( ); Island of Vis 2.07 ( ); ( ); ( ); < ( ); ( ); <0.001 Island of Korčula 1.20 ( ); ( ); ( ); < ( ); < ( ); <0.001 Education (years of schooling, ref: 13) Overall Pp = Overall p = P=0.043 Overall p = P=0.294 Overall p = P= ( ); ( ); ( ); ( ); ( ); ( ); ( ); ( ); ( ); ( ); Material status (ref: 4th quartile) Overall p = P=0.624 Overall p = P=0.055 Overall p = P=0.107 Overall p = P= st quartile 1.47 ( ); ( ); ( ); ( ); ( ); nd quartile 1.32 ( ); ( ); ( ); ( ); ( ); rd quartile 1.12 ( ); ( ); ( ); ( ); ( ); Smoking (ref: never-smokers) Overall p = P=0.803 Overall p = P=0.408 Overall p = P=0.806 Overall p = P= current smokers 0.94( ); ( ); ( ); ( ); ( ); ex-smokers 0.85 ( ); ( ); ( ); ( ); ( ); Alcohol intake (ref: none) Overall p = P=0.196 Overall p = P=0.504 Overall p = P=0.182 Overall p = P= excessive 1.74 ( ); ( ); ( ); ( ); ( ); moderate 1.01 ( ); ( ); ( ); ( ); ( ); MDSS compliance (ref: yes) no 0.86 ( ); ( ); ( ); ( ); ( ); Nut (ref: infrequently or never) Overall p = P=0.350 Overall p = P=0.470 Overall p = P=0.142 Overall p = P=0.303 daily 1.71 ( ); ( ); ( ); ( ); ( ); weekly 1.79 ( ); ( ); ( ); ( ); ( ); monthly 1.21 ( ); ( ); ( ); ( ); ( ); Physical activity (ref: intensive) Overall p = P=0.689 Overall p = P=0.610 Overall P= p = Overall p = P= Formatted: Font: Italic Formatted: Left Formatted: Font: Italic
4 light 1.00 ( ); ( ); ( ); ( ); ( ); moderate 0.83 ( ); ( ); ( ); ( ); ( ); WHtR ( 0.5, ref: yes) no 0.47 ( ); ( ); ( ); ( ); ( ); Hypertension (systolic 140 mmhg or diastolic 90 mmhg or treated for hypertension, ref: yes) no 0.76 ( ); ( ); ( ); ( ); ( ); Diabetes ( 7 mmol/l or treated for diabetes type 2, ref: yes) no 1.89 ( ); ( ); ( ); ( ); ( ); Gout (uric acid 404 μmol/l, 338 μmol/l or gout, ref: yes) no 1.47 ( ); ( ); ( ); ( ); < ( ); MDSS - Mediterranean Diet Serving Score. WHtR - waist-to-height ratio. : males. : woman. Multivariate logistic regression models were built separately for cholesterol, LDL, HDL and triglycerides. Multivariate ordinal regression model was used for the analysis of the characteristics associated with elevated fibrinogen. Adjusted odds ratios, 95% confidence intervals and p-values were calculated using multivariate regression models; each of the five models presented here was simultaneously adjusted for all the covariates listed in this table. Table S3. Characteristics associated with hypertension, diabetes, metabolic syndrome and gout as determined by the multivariate logistic regression analyses (sample size is 897 participants subjects without previous cardiovascular disease CVD diagnosis and older than 65 years of age; all independent variables included in the model are listed in the table). Sex (referent ([ref)]: female) Hypertension (systolic 140 mmhg or diastolic 90 mmhg or treated for hypertension) Diabetes ( 7 mmol/l or treated for diabetes type 2) Elevated HbA1c ( 6.5 mmol/l or treated for diabetes type 2) Metabolic syndrome Gout (uric acid 404 mmol/l mmol/l or gout) male 1.29 ( ); ( ); ( ); ( ); < ( ); Age (years) 0.99 ( ); ( ); ( ); ( ); ( ); Place of residence (ref: Split) Island of Vis 0.59 ( ); ( ); ( ); ( ); ( ); Island of Korčula 1.07 ( ); ( ); ( ); ( ); ( ); Education (years of schooling, ref: 13) Overall p = P=0.007 Overall p = P=0.150 Overall p = P=0.417 Overall p = P=0.653 Overall p = P= ( ); ( ); ( ); ( ); ( ); ( ); ( ); ( ); ( ); ( ); 0.106
5 Material status (ref: 4th quartile) Overall p = P=0.497 Overall p = P=0.031 Overall p = P=0.092 Overall p = P=0.444 Overall p = P= st quartile 0.81 ( ); ( ); ( ); ( ); ( ); nd quartile 0.88 ( ); ( ); ( ); ( ); ( ); rd quartile 0.68 ( ); ( ); ( ); ( ); ( ); Smoking (ref: never-smokers) Overall p = P=0.210 Overall p = P=0.166 Overall p = P=0.347 Overall p = P=0.549 Overall p = P=0.005 current smokers 1.11 ( ); ( ); ( ); ( ); ( ); ex-smokers 0.75 ( ); ( ); ( ); ( ); ( ); Alcohol intake (ref: none) Overall p = P=0.474 Overall p = P=0.473 Overall p = P=0.496 Overall p = P=0.009 Overall p = P=0.220 excessive 0.73 ( ); ( ); ( ); ( ); ( ); moderate 0.92 ( ); ( ); ( ); ( ); ( ); MDSS compliance (ref: yes) no 1.34 ( ); ( ); ( ); ( ); ( ); Nut (ref: infrequently or never) Overall p = P=0.496 Overall p = P=0.583 Overall p = P=0.051 Overall p = P=0.659 Overall p = P=0.968 daily 0.97 ( ); ( ); ( ); ( ); ( ); weekly 1.18 ( ); ( ); ( ); ( ); ( ); monthly 1.32 ( ); ( ); ( ); ( ); ( ); Physical activity (ref: intensive) Overall p = P=0.770 Overall p = P=0.291 Overall p = P=0.336 Overall p = P=0.484 Overall p = P=0.112 light 0.97 ( ); ( ); ( ); ( ); ( ); moderate 0.88 ( ); ( ); ( ); ( ); ( ); WHtR ( 0.5, ref: yes) no 0.61 ( ); ( ); ( ); ( ); < ( ); Hypertension (systolic 140 mmhg or diastolic 90 mmhg or treated for hypertension, ref: yes) no nna 0.67 ( ); ( ); ( ); < ( ); <0.001 Diabetes ( 7 mmol/l or treated for diabetes type 2, ref: yes) no 0.68 ( ); na na 0.21 ( ); < ( ); Metabolic syndrome (ref: yes) no 0.47 ( ); < ( ); < ( ); <0.001 na 0.56 ( ); Gout (uric acid 404 μmol/l μmol/l or gout); yes is referent Formatted Table
6 no 0.50 ( ); < ( ); ( ); ( ); na MDSS - Mediterranean Diet Serving Score. WHtR waist-to-height ratio. na not applicable. : males. : woman. Multivariate logistic regression models were built separately for hypertension, diabetes, metabolic syndrome and gout. Adjusted odds ratios, 95% confidence intervals and p-vp values were calculated using multivariate logistic regression; each of the four models was simultaneously adjusted for all covariates listed in this table, with an exception of excluding predictor variables in models where those variables were the outcome variables (marked with na ). Formatted: Space After: 6 pt, Line spacing: At least 13 pt Formatted: Font: 9 pt, Font color: Black Formatted: MDPI_4.3_table_footer
Know Your Number Aggregate Report Single Analysis Compared to National Averages
Know Your Number Aggregate Report Single Analysis Compared to National s Client: Study Population: 2242 Population: 3,000 Date Range: 04/20/07-08/08/07 Version of Report: V6.2 Page 2 Study Population Demographics
More informationFigure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution
Figure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution of A: total cholesterol (TC); B: low-density lipoprotein
More informationKnow Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up
Know Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up... Study Population: 340... Total Population: 500... Time Window of Baseline: 09/01/13 to 12/20/13... Time Window of Follow-up:
More informationTo reduce the risk of cardiovascular disease and diabetes among Oklahoma state employees.
E Nancy A. Haller, MPH, CHES, Manager, State Wellness Program M PLOYEES To reduce the risk of cardiovascular disease and diabetes among Oklahoma state employees. To suspend or decrease the rising costs
More informationDepok-Indonesia STEPS Survey 2003
The STEPS survey of chronic disease risk factors in Indonesia/Depok was carried out from February 2003 to March 2003. Indonesia/Depok carried out Step 1, Step 2 and Step 3. Socio demographic and behavioural
More informationWAIST-HEIGHT RATIO : A NEW OBESITY INDEX FOR FILIPINOS?
WAIST-HEIGHT RATIO : A NEW OBESITY INDEX FOR FILIPINOS? Consuelo L. Orense, MSPH, Charmaine A. Duante, RMT, MS Epid.(PH), Ermelita N. Bautista, MPH and Lilibeth P. Dasco, MSAN ABSTRACT The study aimed
More informationWhere a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.
Obstructive sleep apnoea and retinopathy in patients with type 2 diabetes Altaf, Quratul-ain; Dodson, Paul; Ali, Asad; Raymond, Neil T; Wharton, Helen; Hampshire- Bancroft, Rachel; Shah, Mirriam; Shepherd,
More informationTotal risk management of Cardiovascular diseases Nobuhiro Yamada
Nobuhiro Yamada The worldwide burden of cardiovascular diseases (WHO) To prevent cardiovascular diseases Beyond LDL Multiple risk factors With common molecular basis The Current Burden of CVD CVD is responsible
More informationEpidemiologic Measure of Association
Measures of Disease Occurrence: Epidemiologic Measure of Association Basic Concepts Confidence Interval for population characteristic: Disease Exposure Present Absent Total Yes A B N 1 = A+B No C D N 2
More informationSince 1980, obesity has more than doubled worldwide, and in 2008 over 1.5 billion adults aged 20 years were overweight.
Impact of metabolic comorbidity on the association between body mass index and health-related quality of life: a Scotland-wide cross-sectional study of 5,608 participants Dr. Zia Ul Haq Doctoral Research
More informationModelling Reduction of Coronary Heart Disease Risk among people with Diabetes
Modelling Reduction of Coronary Heart Disease Risk among people with Diabetes Katherine Baldock Catherine Chittleborough Patrick Phillips Anne Taylor August 2007 Acknowledgements This project was made
More informationCardiovascular Disease Risk Behaviors of Nursing Students in Nursing School
International Journal of Medical Research & Health Sciences Available online at www.ijmrhs.com ISSN No: 2319-5886 International Journal of Medical Research & Health Sciences, 2018, 7(8): 16-33 I J M R
More informationCentral pressures and prediction of cardiovascular events in erectile dysfunction patients
Central pressures and prediction of cardiovascular events in erectile dysfunction patients N. Ioakeimidis, K. Rokkas, A. Angelis, Z. Kratiras, M. Abdelrasoul, C. Georgakopoulos, D. Terentes-Printzios,
More informationSupplemental Table S2: Subgroup analysis for IL-6 with BMI in 3 groups
Supplemental Table S1: Unadjusted and Adjusted Hazard Ratios for Diabetes Associated with Baseline Factors Considered in Model 3 SMART Participants Only Unadjusted Adjusted* Baseline p-value p-value Covariate
More information(n=6279). Continuous variables are reported as mean with 95% confidence interval and T1 T2 T3. Number of subjects
Table 1. Distribution of baseline characteristics across tertiles of OPG adjusted for age and sex (n=6279). Continuous variables are reported as mean with 95% confidence interval and categorical values
More informationSupplementary table 1 Demographic and clinical characteristics of participants by paraoxonase-1 (PON-1) gene polymorphisms
Supplementary table 1 Demographic and clinical characteristics of participants by paraoxonase-1 (PON-1) gene polymorphisms QQ QR/RR n = 36 n = 80 Men (%) 20 (55) 54 (67) 0.216 Age (years) 57 ± 10 56 ±
More informationAndrejs Kalvelis 1, MD, PhD, Inga Stukena 2, MD, Guntis Bahs 3 MD, PhD & Aivars Lejnieks 4, MD, PhD ABSTRACT INTRODUCTION. Riga Stradins University
CARDIOVASCULAR RISK FACTORS ORIGINAL ARTICLE Do We Correctly Assess the Risk of Cardiovascular Disease? Characteristics of Risk Factors for Cardiovascular Disease Depending on the Sex and Age of Patients
More informationAutonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors
Autonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors Carmine Pizzi 1 ; Lamberto Manzoli 2, Stefano Mancini 3 ; Gigliola Bedetti
More informationSerum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic
Supplementary Information The title of the manuscript Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic stroke Xin-Wei He 1, Wei-Ling Li 1, Cai Li
More informationSUPPLEMENTARY DATA. Supplementary Figure S1. Cohort definition flow chart.
Supplementary Figure S1. Cohort definition flow chart. Supplementary Table S1. Baseline characteristics of study population grouped according to having developed incident CKD during the follow-up or not
More informationLogistic Regression Predicting the Chances of Coronary Heart Disease. Multivariate Solutions
Logistic Regression Predicting the Chances of Coronary Heart Disease Multivariate Solutions What is Logistic Regression? Logistic regression in a nutshell: Logistic regression is used for prediction of
More informationSUPPLEMENTAL MATERIAL. Materials and Methods. Study design
SUPPLEMENTAL MATERIAL Materials and Methods Study design The ELSA-Brasil design and concepts have been detailed elsewhere 1. The ELSA-Brasil is a cohort study of active or retired 15,105 civil servants,
More informationAppendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors.
Appendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors. Appendix to: Banks E, Crouch SR, Korda RJ, et al. Absolute risk of cardiovascular
More informationAUTONOMIC FUNCTION IS A HIGH PRIORITY
AUTONOMIC FUNCTION IS A HIGH PRIORITY 1 Bladder-Bowel-AD Tetraplegia Sexual function Walking Bladder-Bowel-AD Paraplegia Sexual function Walking 0 10 20 30 40 50 Percentage of respondents an ailment not
More informationCardiovascular Risk Assessment and Management Making a Difference
Cardiovascular Risk Assessment and Management Making a Difference Norman Sharpe March 2014 Numbers and age-standardised mortality rates from all causes, by sex, 1950 2010 Death rates halved Life expectancy
More informationElevated Serum Levels of Adropin in Patients with Type 2 Diabetes Mellitus and its Association with
Elevated Serum Levels of Adropin in Patients with Type 2 Diabetes Mellitus and its Association with Insulin Resistance Mehrnoosh Shanaki, Ph.D. Assistant Professor of Clinical Biochemistry Shahid Beheshti
More informationSupplementary Online Content
Supplementary Online Content Pedersen SB, Langsted A, Nordestgaard BG. Nonfasting mild-to-moderate hypertriglyceridemia and risk of acute pancreatitis. JAMA Intern Med. Published online November 7, 2016.
More informationBasic Biostatistics. Chapter 1. Content
Chapter 1 Basic Biostatistics Jamalludin Ab Rahman MD MPH Department of Community Medicine Kulliyyah of Medicine Content 2 Basic premises variables, level of measurements, probability distribution Descriptive
More informationPopulation: All participants Number of Obs: Variable # Sas Name: Sas Label: Categories: Variable # Sas Name: F80VNUM. Sas Label: Categories:
Form - Last Update: 04/6/001 umber of Obs: 161771 Participant ID 1 ID Participant ID F Days since randomization/enrollment 161771-886 8-59451 516548 FDAYS F Days since randomization/enrollment F Visit
More informationSupplemental table 1. Dietary sources of protein among 2441 men from the Kuopio Ischaemic Heart Disease Risk Factor Study MEAT DAIRY OTHER ANIMAL
ONLINE DATA SUPPLEMENT 1 SUPPLEMENTAL MATERIAL Pork Bacon Turkey Kidney Cream Cottage cheese Mutton and lamb Game (elk, reindeer) Supplemental table 1. Dietary sources of protein among 2441 men from the
More informationASSeSSing the risk of fatal cardiovascular disease
ASSeSSing the risk of fatal cardiovascular disease «Systematic Cerebrovascular and coronary Risk Evaluation» think total vascular risk Assess the risk Set the targets Act to get to goal revised; aupril
More informationAPPENDIX AVAILABLE ON THE HEI WEB SITE
APPENDIX AVAILABLE ON THE HEI WEB SITE Research Report 178 National Particle Component Toxicity (NPACT) Initiative Report on Cardiovascular Effects Sverre Vedal et al. Section 1: NPACT Epidemiologic Study
More informationTrends In CVD, Related Risk Factors, Prevention and Control In China
Trends In CVD, Related Risk Factors, Prevention and Control In China Youfa Wang, MD, MS, PhD Associate Professor Center for Human Nutrition Department of International Health Department of Epidemiology
More informationSupplementary Online Content
Supplementary Online Content Leibowitz M, Karpati T, Cohen-Stavi CJ, et al. Association between achieved low-density lipoprotein levels and major adverse cardiac events in patients with stable ischemic
More informationAssociation between Raised Blood Pressure and Dysglycemia in Hong Kong Chinese
Diabetes Care Publish Ahead of Print, published online June 12, 2008 Raised Blood Pressure and Dysglycemia Association between Raised Blood Pressure and Dysglycemia in Hong Kong Chinese Bernard My Cheung,
More information290 Biomed Environ Sci, 2016; 29(4):
290 Biomed Environ Sci, 2016; 29(4): 290-294 Letter to the Editor Prevalence and Predictors of Hypertension in the Labor Force Population in China: Results from a Cross-sectional Survey in Xinjiang Uygur
More informationGlycemic index, glycemic load, and the risk of acute myocardial infarction in middle-aged Finnish men:
Glycemic index, glycemic load, and the risk of acute myocardial infarction in middle-aged Finnish men: The Kuopio Ischaemic Heart Disease Risk Factor Study Jaakko Mursu, Jyrki K. Virtanen, Tiina H. Rissanen,
More informationSupplementary Online Content
Supplementary Online Content Clair C, Rigotti NA, Porneala B, et al. Association of smoking cessation and weight change with cardiovascular disease among people with and without diabetes. JAMA. doi:10.1001/jama.2013.1644.
More informationprogramme. The DE-PLAN follow up.
What are the long term results and determinants of outcomes in primary health care diabetes prevention programme. The DE-PLAN follow up. Aleksandra Gilis-Januszewska, Noël C Barengo, Jaana Lindström, Ewa
More informationStatin therapy in patients with Mild to Moderate Coronary Stenosis by 64-slice Multidetector Coronary Computed Tomography
Statin therapy in patients with Mild to Moderate Coronary Stenosis by 64-slice Multidetector Coronary Computed Tomography Hyo Eun Park 1, Eun-Ju Chun 2, Sang-Il Choi 2, Soyeon Ahn 2, Hyung-Kwan Kim 3,
More informationJUPITER NEJM Poll. Panel Discussion: Literature that Should Have an Impact on our Practice: The JUPITER Study
Panel Discussion: Literature that Should Have an Impact on our Practice: The Study Kaiser COAST 11 th Annual Conference Maui, August 2009 Robert Blumberg, MD, FACC Ralph Brindis, MD, MPH, FACC Primary
More informationCARE PATHWAYS. Allyson Ashley
CARE PATHWAYS Allyson Ashley WHAT IS A CARE PATHWAY? An explicit statement of the goals and key elements of care based on evidence, best practice, and patient s expectations and their characteristics The
More informationORIGINAL INVESTIGATION. C-Reactive Protein Concentration and Incident Hypertension in Young Adults
ORIGINAL INVESTIGATION C-Reactive Protein Concentration and Incident Hypertension in Young Adults The CARDIA Study Susan G. Lakoski, MD, MS; David M. Herrington, MD, MHS; David M. Siscovick, MD, MPH; Stephen
More informationMetabolic Syndrome and Workplace Outcome
Metabolic Syndrome and Workplace Outcome Maine Worksite Wellness Initiative June 15, 2010 Alyssa B. Schultz Dee W. Edington Current Definition* of Metabolic Syndrome At least 3 of the following: Waist
More informationBiases in clinical research. Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University
Biases in clinical research Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University Learning objectives Describe the threats to causal inferences in clinical studies Understand the role of
More informationJohn J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam
Latest Insights from the JUPITER Study John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam Inflammation, hscrp, and Vascular Prevention
More informationSupplementary Table 1. The distribution of IFNL rs and rs and Hardy-Weinberg equilibrium Genotype Observed Expected X 2 P-value* CHC
Supplementary Table 1. The distribution of IFNL rs12979860 and rs8099917 and Hardy-Weinberg equilibrium Genotype Observed Expected X 2 P-value* CHC rs12979860 (n=3129) CC 1127 1145.8 CT 1533 1495.3 TT
More informationPrevalence of Comorbidities among HIV-positive patients in Taiwan
Prevalence of Comorbidities among HIV-positive patients in Taiwan Chien-Ching Hung, MD, PhD Department of Internal Medicine National Taiwan University Hospital, Taipei, Taiwan % of participants Comorbidity
More informationSmall dense low-density lipoprotein is a risk for coronary artery disease in an urban Japanese cohort: The Suita study
Small dense low-density lipoprotein is a risk for coronary artery disease in an urban Japanese cohort: The Suita study Hidenori Arai 1, Yoshihiro Kokubo 2, Makoto Watanabe 2, Tatsuya Sawamura 3, Tomonori
More informationMetabolic Syndrome: A Preventable & Treatable Cluster of Conditions
Metabolic Syndrome: A Preventable & Treatable Cluster of Conditions April D. McNeill MD Candidate 2016, Southern Illinois University, School of Medicine GE-NMF Primary Care Leadership Program, July 2013
More informationCVD Prevention, Who to Consider
Continuing Professional Development 3rd annual McGill CME Cruise September 20 27, 2015 CVD Prevention, Who to Consider Dr. Guy Tremblay Excellence in Health Care and Lifelong Learning Global CV risk assessment..
More informationRisk Factors for Heart Disease
Risk Factors for Heart Disease Risk Factors we cannot change (Age, Gender, Family History) Risk Factors we can change (modifiable) Smoking Blood pressure Cholesterol Diabetes Inactivity Overweight Stress
More informationwell-targeted primary prevention of cardiovascular disease: an underused high-value intervention?
well-targeted primary prevention of cardiovascular disease: an underused high-value intervention? Rod Jackson University of Auckland, New Zealand October 2015 Lancet 1999; 353: 1547-57 Findings: Contribution
More information300 Biomed Environ Sci, 2018; 31(4):
300 Biomed Environ Sci, 2018; 31(4): 300-305 Letter to the Editor Combined Influence of Insulin Resistance and Inflammatory Biomarkers on Type 2 Diabetes: A Population-based Prospective Cohort Study of
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Solomon SD, Uno H, Lewis EF, et al. Erythropoietic response
More informationSupplementary Online Content
Supplementary Online Content Larsen JR, Vedtofte L, Jakobsen MSL, et al. Effect of liraglutide treatment on prediabetes and overweight or obesity in clozapine- or olanzapine-treated patients with schizophrenia
More informationNational Collaborative Wave 2 (Wave 9): National Diabetes Prevention and Management Wave, Month 9 Diabetes Management: Diabetes Register
National Collaborative Wave 2 (Wave 9): National Diabetes Prevention and Management Wave, Month 9 Diabetes Management: Diabetes Register The above graph shows a decrease in the number of patients on the
More informationTrial to Reduce. Aranesp* Therapy. Cardiovascular Events with
Trial to Reduce Cardiovascular Events with Aranesp* Therapy John J.V. McMurray, Hajime Uno, Petr Jarolim, Akshay S. Desai, Dick de Zeeuw, Kai-Uwe Eckardt, Peter Ivanovich, Andrew S. Levey, Eldrin F. Lewis,
More information902 Biomed Environ Sci, 2014; 27(11):
902 Biomed Environ Sci, 2014; 27(11): 902-906 Letter to the Editor Curcuminoids Target Decreasing Serum Adipocyte-fatty Acid Binding Protein Levels in Their Glucose-lowering Effect in Patients with Type
More informationSCIENTIFIC STUDY REPORT
PAGE 1 18-NOV-2016 SCIENTIFIC STUDY REPORT Study Title: Real-Life Effectiveness and Care Patterns of Diabetes Management The RECAP-DM Study 1 EXECUTIVE SUMMARY Introduction: Despite the well-established
More informationPERCEPTION OF CVD RISK FACTORS BY DIFFERENT STAKEHOLDERS - DOCTORS, MEDICAL STUDENTS, GENERAL PUBLIC, POLITICIANS, JOURNALISTS Professor ŽeljkoReiner,
PERCEPTION OF CVD RISK FACTORS BY DIFFERENT STAKEHOLDERS - DOCTORS, MEDICAL STUDENTS, GENERAL PUBLIC, POLITICIANS, JOURNALISTS Professor ŽeljkoReiner, MD,PhD,FRCP(Lond),FESC,FACC University Hospital Center
More informationMOLINA HEALTHCARE OF CALIFORNIA
MOLINA HEALTHCARE OF CALIFORNIA HIGH BLOOD CHOLESTEROL IN ADULTS GUIDELINE Molina Healthcare of California has adopted the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel
More informationOriginal Research Article
A STUDY TO ESTIMATE SUBCLINICAL ATHEROSCLEROSIS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS BY MEASURING THE CAROTID INTIMAL MEDIAL THICKNESS Natarajan Kandasamy 1, Rajan Ganesan 2, Thilakavathi Rajendiran
More informationARIC Manuscript Proposal # 1518
ARIC Manuscript Proposal # 1518 PC Reviewed: 5/12/09 Status: A Priority: 2 SC Reviewed: Status: Priority: 1. a. Full Title: Prevalence of kidney stones and incidence of kidney stone hospitalization in
More informationEffective Interventions in the Clinical Setting: Engaging and Empowering Patients. Michael J. Bloch, M.D. Doina Kulick, M.D.
Effective Interventions in the Clinical Setting: Engaging and Empowering Patients Michael J. Bloch, M.D. Doina Kulick, M.D. UNIVERSITY OF NEVADA SCHOOL of MEDICINE Sept. 8, 2011 Reality check: What could
More informationHypertriglyceridemia and the Related Factors in Middle-aged Adults in Taiwan
1 Hypertriglyceridemia and the Related Factors in Middle-aged Adults in Taiwan Cheng-Chieh Lin, Tsai-Chung Li 2, Shih-Wei Lai, Kim-Choy Ng 1, Kuo-Che Wang, Chiu-Shong Liu Department of Community Medicine,
More informationCHAPTER 3 DIABETES MELLITUS, OBESITY, HYPERTENSION AND DYSLIPIDEMIA IN ADULT CENTRAL KERALA POPULATION
CHAPTER 3 DIABETES MELLITUS, OBESITY, HYPERTENSION AND DYSLIPIDEMIA IN ADULT CENTRAL KERALA POPULATION 3.1 BACKGROUND Diabetes mellitus (DM) and impaired glucose tolerance (IGT) have reached epidemic proportions
More informationHow to Reduce CVD Complications in Diabetes?
How to Reduce CVD Complications in Diabetes? Chaicharn Deerochanawong M.D. Diabetes and Endocrinology Unit Department of Medicine Rajavithi Hospital, Ministry of Public Health Framingham Heart Study 30-Year
More informationCARDIOVASCULAR RISK FACTORS & TARGET ORGAN DAMAGE IN GREEK HYPERTENSIVES
CARDIOVASCULAR RISK FACTORS & TARGET ORGAN DAMAGE IN GREEK HYPERTENSIVES C. Liakos, 1 G. Vyssoulis, 1 E. Karpanou, 2 S-M. Kyvelou, 1 V. Tzamou, 1 A. Michaelides, 1 A. Triantafyllou, 1 P. Spanos, 1 C. Stefanadis
More informationTHE EFFECT OF SECONDHAND SMOKE EXPOSURE ON HIGH MOLECULAR WEIGHT ADIPONECTIN LEVELS IN ADULT WOMEN: A PRELIMINARY REPORT
THE EFFECT OF SECONDHAND SMOKE EXPOSURE ON HIGH MOLECULAR WEIGHT ADIPONECTIN LEVELS IN ADULT WOMEN: A PRELIMINARY REPORT Siti Hajar MH 1, Harmy MY 1, Norhayati MN 1, Aida HGR 2, Hamid JJM 3 Department
More informationLEPTIN AS A NOVEL PREDICTOR OF DEPRESSION IN PATIENTS WITH THE METABOLIC SYNDROME
LEPTIN AS A NOVEL PREDICTOR OF DEPRESSION IN PATIENTS WITH THE METABOLIC SYNDROME Diana A. Chirinos, Ronald Goldberg, Elias Querales-Mago, Miriam Gutt, Judith R. McCalla, Marc Gellman and Neil Schneiderman
More informationEffect of Combined Interventions of Diet and Physical Activity on the Perceived and Actual Risk of Coronary
World Journal of Medical Sciences 9 (4): 282-288, 2013 ISSN 1817-3055 IDOSI Publications, 2013 DOI: 10.5829/idosi.wjms.2013.9.4.12383 Effect of Combined Interventions of Diet and Physical Activity on the
More informationThe State of Play of Diabetes Indicators
The State of Play of Diabetes Indicators South Australian and National Information Catherine Chittleborough Janet Grant Anne Taylor April 2003 Diabetes Clearing House Population Research and Outcome Studies
More informationModule 2. Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension
Module 2 Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension 1 Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored,
More informationOptimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden
Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Cardiovascular Disease Prevention (CVD) Three Strategies for CVD
More informationLack of documentation on overweight & obese status in patients admitted to the coronary care unit: Results from the CCU study
Lack of documentation on overweight & obese status in patients admitted to the coronary care unit: Results from the CCU study Meriam F. Caboral,, RN, MSN, NP-C Clinical Coordinator Heart Failure Components
More informationPREVALENCE OF AND FACTORS ASSOCIATED WITH OBSTRUCTIVE SLEEP APNEA IN A COHORT OF ADULTS WITH LONG DURATION TYPE 1 DIABETES MELLITUS.
PREVALENCE OF AND FACTORS ASSOCIATED WITH OBSTRUCTIVE SLEEP APNEA IN A COHORT OF ADULTS WITH LONG DURATION TYPE 1 DIABETES MELLITUS by Hristina Denić BS in Nursing, Indiana University of Pennsylvania,
More information30% of patients with T2D have high levels of urine albumin at diagnosis: 75% MAU 25% overt diabetic nephropathy
Identifying Patients with Type 2 Diabetes at High Risk of Microalbuminuria: the DEMAND (Developing Education on Microalbuminuria for Awareness of renal and cardiovascular risk in Diabetes) Study. Rossi
More informationBariatric Surgery versus Intensive Medical Therapy for Diabetes 3-Year Outcomes
The new england journal of medicine original article Bariatric Surgery versus Intensive Medical for Diabetes 3-Year Outcomes Philip R. Schauer, M.D., Deepak L. Bhatt, M.D., M.P.H., John P. Kirwan, Ph.D.,
More informationDiabetes and Cardiovascular risk factors among Oil Sector Workers in the State of Kuwait (2013 KOC Periodical Medical Exam.)
Diabetes and Cardiovascular risk factors among Oil Sector Workers in the State of Kuwait (2013 KOC Periodical Medical Exam.) Mohammad Hasan, RN, CMIOSH Brief about KOC Kuwait Oil Company (KOC) is a state
More informationRelationship between cardiovascular risk factors and traditional Chinese constitution in subjects with high-normal blood pressure
World Journal of Cardiovascular Diseases, 2013, 3, 234-238 http://dx.doi.org/10.4236/wjcd.2013.32036 Published Online April 2013 (http://www.scirp.org/journal/wjcd/) WJCD Relationship between cardiovascular
More informationPharmacist Assessment of Adherence, Risk and Treatment in Cardiovascular Disease (PAART CVD)
Pharmacist Assessment of Adherence, Risk and Treatment in Cardiovascular Disease (PAART CVD) Researchers: Kevin Mc Namara (Principal Investigator), Dr Stephen Bunker, Prof James Dunbar, Gregory Duncan,
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery
More informationChoosing the Correct Statistical Test
Choosing the Correct Statistical Test T racie O. Afifi, PhD Departments of Community Health Sciences & Psychiatry University of Manitoba Department of Community Health Sciences COLLEGE OF MEDICINE, FACULTY
More informationABSTRACT: 9 DOES SOY CONSUMPTION HAVE AN EFFECT ON HYPERTENSION IN LOW-INCOME RURAL SOUTH AFRICAN WOMEN?
ABSTRACT: 9 DOES SOY CONSUMPTION HAVE AN EFFECT ON HYPERTENSION IN LOW-INCOME RURAL SOUTH AFRICAN WOMEN? W.H. OLDEWAGE-THERON & A.A. EGAL Centre of Sustainable Livelihoods, Vaal University of Technology,
More informationImpact of Body Mass Index and Metabolic Syndrome on the Characteristics of Coronary Plaques Using Computed Tomography Angiography
Impact of Body Mass Index and Metabolic Syndrome on the Characteristics of Coronary Plaques Using Computed Tomography Angiography Cardiovascular Division, Faculty of Medicine, University of Tsukuba Akira
More informationRationale: Objectives: Indication: Diabetes Mellitus, Type 2 Study Investigators/Centers: 300 physicians in 292 clinics Research Methods: Data Source:
GSK Medicine: N/A Study No.: 112255 Title: A Korean, multi-center, nation-wide, cross-sectional, epidemiology study to identify prevalence of diabetic nephropathy in hypertensive patients with type 2 diabetes
More informationObesity Prevention and Control: Provider Education with Patient Intervention
Obesity Prevention and : Provider Education with Patient Summary Evidence Table and Population Cohen et al. (1991) 1987-1988 : RCT Location: Pittsburgh, PA Physician training session by a behavioral psychologist
More informationTable S2: Anthropometric, clinical, cardiovascular and appetite outcome changes over 8 weeks (baseline-week 8) by snack group
Table S1: Nutrient composition of cracker and almond snacks Cracker* Almond** Weight, g 77.5 g (5 sheets) 56.7 g (2 oz.) Energy, kcal 338 364 Carbohydrate, g (kcal) 62.5 12.6 Dietary fiber, g 2.5 8.1 Protein,
More informationIs Knowing Half the Battle? Behavioral Responses to Risk Information from the National Health Screening Program in Korea
Is Knowing Half the Battle? Behavioral Responses to Risk Information from the National Health Screening Program in Korea Hyuncheol Bryant Kim 1, Suejin A. Lee 1, and Wilfredo Lim 2 1 Cornell University
More informationImpact of Physical Activity on Metabolic Change in Type 2 Diabetes Mellitus Patients
2012 International Conference on Life Science and Engineering IPCBEE vol.45 (2012) (2012) IACSIT Press, Singapore DOI: 10.7763/IPCBEE. 2012. V45. 14 Impact of Physical Activity on Metabolic Change in Type
More informationScreening Results. Juniata College. Juniata College. Screening Results. October 11, October 12, 2016
Juniata College Screening Results Juniata College Screening Results October 11, 2016 & October 12, 2016 JUNIATA COLLEGE The J.C. Blair Hospital CARES team screened 55 Juniata College employees on October
More informationEpidemiology and Prevention
Epidemiology and Prevention Associations of Pregnancy Complications With Calculated Cardiovascular Disease Risk and Cardiovascular Risk Factors in Middle Age The Avon Longitudinal Study of Parents and
More informationSupplementary Note Details of the patient populations studied Strengths and weakness of the study
Supplementary Note Details of the patient populations studied TVD and NCA patients. Patients were recruited to the TVD (triple vessel disease) group who had significant coronary artery disease (defined
More informationSITA 100 mg (n = 378)
Supplementary Table 1. Summary of Sulfonylurea Background Therapy at Baseline and During the Treatment Period. Sulfonylurea at baseline, n (%) SITA 100 mg (n = 378) CANA 300 mg (n = 377) Total (N = 755)
More informationGuidelines on cardiovascular risk assessment and management
European Heart Journal Supplements (2005) 7 (Supplement L), L5 L10 doi:10.1093/eurheartj/sui079 Guidelines on cardiovascular risk assessment and management David A. Wood 1,2 * 1 Cardiovascular Medicine
More informationPIEDMONT ACCESS TO HEALTH SERVICES, INC. Guidelines for Screening and Management of Dyslipidemia
PIEDMONT ACCESS TO HEALTH SERVICES, INC. Policy Number: 01-09-021 SUBJECT: Guidelines for Screening and Management of Dyslipidemia EFFECTIVE DATE: 04/2008 REVIEWED/REVISED: 04/12/10, 03/17/2011, 4/10/2012,
More informationGender Differences in Physical Inactivity and Cardiac Events in Men and Women with Type 2 Diabetes
Gender Differences in Physical Inactivity and Cardiac Events in Men and Women with Type 2 Diabetes Margaret M. McCarthy 1 Lawrence Young 2 Silvio Inzucchi 2 Janice Davey 2 Frans J Th Wackers 2 Deborah
More informationShiftwork and cardiometabolic outcomes. Dr Anil Adisesh
Shiftwork and cardiometabolic outcomes Dr Anil Adisesh 1 FACULTY/PRESENTER DISCLOSURE Faculty: Dr Anil Adisesh Relationships with commercial interests: - None 2 Aims 1) Participants will be able to describe
More informationRehabilitation and Research Training Center on Secondary Conditions in Individuals with SCI. James S. Krause, PhD
Disclosure The contents of this presentation were developed with support from educational grants from the Department of Education, NIDRR grant numbers H133B090005, H133B970011 and H133G010160. However,
More information